Clinical Trial Update: A Study to Investigate Efficacy and Safety of SAR442970 in Patients With Crohn's Disease [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is investigating the efficacy and safety of SAR442970 in patients with Crohn's disease; recruitment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease

Drugs mentioned

• SAR442970

Snippet

Sponsor: Sanofi | Conditions: Crohn's Disease | Phase 2 | Status: RECRUITING